中山便血是什么原因(中山总是放屁是怎么回事) (今日更新中)

NEW YORK, Dec. 27 (Xinhua) -- New York City Mayor Michael Bloomberg announced on Tuesday that babies born in the city in 2009 have the record high life expectancy of 80.6 years, an increase of nearly three years since 2000.The rate of 80.6 years is also above the U.S. national rate of 78.2 years. Life expectancy for 40-year-olds in New York increased by 2.5 years (79.5 to 82) from 2000 to 2009, outpacing the national trend of 1.2 year-increase for the same age group in the U.S. as a whole."If you have friends and relatives that you deeply care about, and they live elsewhere, on average if they move to New York City, they will live longer," said Mayor Michael Bloomberg at Lincoln Hospital in Bronx.Bloomberg contributed the life expectancy progress to the city' s health interventions, including its anti-smoking campaign and expanded testing and treatment for the HIV virus.Despite the progress, heart disease, cancer and influenza/ pneumonia continue to rank as the top three leading causes of death in New York City, followed by lung disease and diabetes.

BEIJING, Nov. 30 (Xinhua) -- China's efforts to fight AIDS are impressive and its experience can be shared, according to Michel Sidibe, executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS)."We have seen progress in terms of new infections. The number of people going into treatment is increasing and the mortality rate is going down very quickly in China," Sidibe said during an interview with Xinhua on Wednesday.Sidibe said he was impressed by the country's political leadership and commitment to controlling AIDS.According to UNAIDS, the country has reported a 60-percent reduction in deaths due to AIDS over the past eight years.New HIV infection cases in China have been reduced from 70,000 people annually in 2005 to around 48,000 in 2011, according to the country's health department."However, China's success will not only be measured by what it has done for the Chinese people," Sidibe said.China has successful experience in reducing new HIV infections among intravenous drug users, which can be shared with the rest of the world, particularly east Europe and south Asia where HIV infections among drug abusers is a major challenge, he said.Sidibe suggested that the country should work with the rest of the developing world, particularly Africa, in fighting AIDS.A partnership between China and Africa will make a "big, big difference" in reducing AIDS mortality rates and introducing new technology and perspectives in Africa, said the official who had worked for UN in several African countries for more than two decades.Admitting the challenges of funding AIDS control programs during the current global economic downturn, Sidibe called for global solidarity and increasing shared responsibilities among countries."It is a critical moment now. It is not a time to stop investment but to redouble our efforts, to make sure that we will continue to make progress in the fight against HIV," Sidibe said."Getting to Zero" has been chosen as the main theme of World AIDS Day for the next five years, referring to UNAIDS' vision of "zero new HIV infections, zero discrimination and zero AIDS-related deaths."Sidibe met with Li Congjun, president of the Xinhua News Agency, on Wednesday before the interview. The agency has launched a global media campaign in cooperation with UNAIDS to raise public awareness about HIV/AIDS."The partnership (with Xinhua) is not only about writing news about HIV. It is about helping people to change their attitude and make decisions to help protect themselves," Sidibe said.

BEIJING, Jan. 23 (Xinhua) -- Nearly 200,000 local residents and tourists visited parks in Beijing on Monday as a series of celebrations were hosted to mark the first day of the Chinese lunar New Year, the city's park administration said.Festive activities kicked off at Beijing's famous parks, including the Temple of Heaven, the Summer Palace, and the Beihai Park, on Monday to welcome the Year of the Dragon, said Chen Zhiqiang, spokesman for the Beijing Municipal Administration Center of Parks.At the Temple of Heaven, 320 costumed performers on Monday staged a show presenting the royal heaven worship ceremony in the Qing Dynasty (1644-1911).In the one-hour ceremony, thousands of visitors watched as the royal parade marched toward the altar where the "emperor" held a ritual to pray for peace and good harvest in the coming year.At the Summer Palace, the ancient royal garden, a traditional fair opened to public with old-fashioned shops and stands selling items and snacks popular in the old days.The Chinese New Year, which begins on Monday this year, is an important occasion for family dinners, fireworks, and a trip to temple fairs.To cope with the increase in visitors, authorities in Beijing said they have deployed seven police choppers and 910,000 order-maintaining personnel across the city to prevent the breakout of fires and stampedes.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

来源：资阳报